Finance

Lists
6541:TPE
Tanvex Biopharma Inc
28,15 NT$
+0,18%
(+0,050) 1D
16 նոյ, 09:32:04 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6541...
Open
28,50 NT$
High
28,50 NT$
Low
27,80 NT$
Mkt. cap
7,47 մլրդ
Avg. vol.
458,98 հզր
Volume
41,00 հզր
52-wk high
65,50 NT$
52-wk low
24,30 NT$
EPS
-5,56 NT$
Shares outstanding
242,67 մլն
No. of employees
215
Open
28,50 NT$
High
28,50 NT$
Low
27,80 NT$
Mkt. cap
7,47 մլրդ
Avg. vol.
458,98 հզր
Volume
41,00 հզր
52-wk high
65,50 NT$
52-wk low
24,30 NT$
EPS
-5,56 NT$
Shares outstanding
242,67 մլն
No. of employees
215
News stories
From web sources and news partners
About Tanvex Biopharma Inc
CEO-
Employees215
Founded2011
Headquarters-
SectorHealth Care
Industry-
Websitetanvex.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
178,95 մլն
132,83 մլն
220,44 մլն
158,84 մլն
Cost of goods sold
422,66 մլն
399,36 մլն
446,37 մլն
399,62 մլն
Cost of revenue
422,66 մլն
399,36 մլն
446,37 մլն
399,62 մլն
Research and development expenses
13,26 մլն
24,24 մլն
19,86 մլն
10,67 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104,26 մլն
108,51 մլն
121,17 մլն
108,24 մլն
Operating expense
129,86 մլն
133,70 մլն
141,15 մլն
118,94 մլն
Total operating expenses
552,52 մլն
533,06 մլն
587,52 մլն
518,56 մլն
Operating income
-373,57 մլն
-400,23 մլն
-367,07 մլն
-359,72 մլն
Other non operating income
44,99 մլն
188,00 հզր
418,00 հզր
-30,58 մլն
EBT including unusual items
-420,53 մլն
-388,70 մլն
-382,53 մլն
-405,98 մլն
EBT excluding unusual items
-305,62 մլն
-388,70 մլն
-382,53 մլն
-405,98 մլն
Income tax expense
3,00 հզր
27,00 հզր
1,00 հզր
-5,84 մլն
Effective tax rate
-
-0,01%
-
1,44%
Other operating expenses
-
-
-
25,00 հզր
Net income
-420,54 մլն
-388,72 մլն
-382,53 մլն
-400,14 մլն
Net profit margin
-235,00%
-292,65%
-173,53%
-251,92%
Earnings per share
-
-
-
-
Interest and investment income
11,66 մլն
6,03 մլն
5,01 մլն
5,72 մլն
Interest expense
-11,31 մլն
-11,70 մլն
-16,53 մլն
-21,40 մլն
Net interest expenses
354,00 հզր
-5,67 մլն
-11,52 մլն
-15,68 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-370,64 մլն
-357,68 մլն
-326,85 մլն
-164,28 մլն
Gain or loss from assets sale
62,12 մլն
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google Apps